Synonym
CI-628 citrate; CI628 citrate; CI 628 citrate; Parke davis CI-628; Nitromifene Citrate
IUPAC/Chemical Name
(Z)-1-(2-(4-(1-(4-methoxyphenyl)-2-nitro-2-phenylvinyl)phenoxy)ethyl)pyrrolidine 2-hydroxypropane-1,2,3-tricarboxylate
InChi Key
LHAPNDAERSFWSC-JTHROIFXSA-N
InChi Code
InChI=1S/C27H28N2O4.C6H8O7/c1-32-24-13-9-21(10-14-24)26(27(29(30)31)23-7-3-2-4-8-23)22-11-15-25(16-12-22)33-20-19-28-17-5-6-18-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h2-4,7-16H,5-6,17-20H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b27-26-;
SMILES Code
O=[N+](/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN3CCCC3)C=C2)/C4=CC=C(OC)C=C4)[O-].O=C(CC(C(O)=O)(O)CC(O)=O)O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Biological target:
Nitromifene Citrate is a non-steroidal estrogen antagonist (as the 1:1 citrate).
Preparing Stock Solutions
The following data is based on the
product
molecular weight
636.65
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Henley CL, Nunez AA, Clemens LG. Hormones of choice: the neuroendocrinology of partner preference in animals. Front Neuroendocrinol. 2011 Apr;32(2):146-54. doi: 10.1016/j.yfrne.2011.02.010. Epub 2011 Mar 4. Review. PubMed PMID: 21377487.
2: Nakamura NH, McEwen BS. Changes in interneuronal phenotypes regulated by estradiol in the adult rat hippocampus: a potential role for neuropeptide Y. Neuroscience. 2005;136(1):357-69. Epub 2005 Sep 28. PubMed PMID: 16198490.
3: Rudick CN, Woolley CS. Selective estrogen receptor modulators regulate phasic activation of hippocampal CA1 pyramidal cells by estrogen. Endocrinology. 2003 Jan;144(1):179-87. PubMed PMID: 12488344.
4: Young EA, Altemus M, Parkison V, Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology. 2001 Dec;25(6):881-91. PubMed PMID: 11750181.
5: McEwen BS, Tanapat P, Weiland NG. Inhibition of dendritic spine induction on hippocampal CA1 pyramidal neurons by a nonsteroidal estrogen antagonist in female rats. Endocrinology. 1999 Mar;140(3):1044-7. PubMed PMID: 10067823.
6: Kisley LR, Sakai RR, Ma LY, Fluharty SJ. Ovarian steroid regulation of angiotensin II-induced water intake in the rat. Am J Physiol. 1999 Jan;276(1 Pt 2):R90-6. PubMed PMID: 9887181.
7: Vega Matuszczyk J, Appa RS, Larsson K. Postnatal testicular secretions partially restore the disturbances in reproductive activity caused by prenatal hormonal manipulation. Physiol Behav. 1997 Jul;62(1):137-43. PubMed PMID: 9226353.
8: Vega Matuszczyk JV, Larsson K. Sexual preference and feminine and masculine sexual behavior of male rats prenatally exposed to antiandrogen or antiestrogen. Horm Behav. 1995 Jun;29(2):191-206. PubMed PMID: 7557922.
9: Sayag N, Snapir N, Arnon E, el Halawani ME, Grimm VE, Robinzon B. Sexual differentiation of copulatory behaviour in the male chick requires gonadal steroids. Br Poult Sci. 1991 Jul;32(3):607-17. PubMed PMID: 1893270.
10: Schlinger BA, Callard GV. Aromatization mediates aggressive behavior in quail. Gen Comp Endocrinol. 1990 Jul;79(1):39-53. PubMed PMID: 2191894.
11: Huet-Hudson YM, Dey SK. Differential effects of ovarian steroids and triphenylethylene compounds on macromolecular uptake and thymidine incorporation in the mouse uterus. J Steroid Biochem. 1990 Jan;35(1):23-7. PubMed PMID: 2407900.
12: Ruenitz PC, Thompson CB, Srivatsan V. Characterization of MCF 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolites. J Steroid Biochem. 1989 Sep;33(3):365-9. PubMed PMID: 2550704.
13: Dumesic DA, Renk M, Kamel F. Estrogenic effects of phenol red on rat pituitary cell responsiveness to gonadotropin-releasing hormone. Life Sci. 1989;44(6):397-406. PubMed PMID: 2645497.
14: Fargin A, Faye JC, le Maire M, Bayard F, Potier M, Beauregard G. Solubilization of a tamoxifen-binding protein. Assessment of its molecular mass. Biochem J. 1988 Nov 15;256(1):229-36. PubMed PMID: 3066343; PubMed Central PMCID: PMC1135392.
15: Pasqualini JR, Sumida C, Giambiagi N. Pharmacodynamic and biological effects of anti-estrogens in different models. J Steroid Biochem. 1988 Oct;31(4B):613-43. Review. PubMed PMID: 3059059.
16: Huet YM, Dey SK. A paradoxical effect of an antiestrogen, CI-628, on implantation in the mouse. Proc Soc Exp Biol Med. 1988 Oct;189(1):61-5. PubMed PMID: 3054903.
17: Borgna JL, Scali J. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate. J Steroid Biochem. 1988 Oct;31(4A):427-36. PubMed PMID: 3050278.
18: Juriansz RL, Huseby RA, Wilcox RB. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia. Cancer Res. 1988 Jan 1;48(1):14-8. PubMed PMID: 3334987.
19: Huet YM, Dey SK. Role of early and late oestrogenic effects on implantation in the mouse. J Reprod Fertil. 1987 Nov;81(2):453-8. PubMed PMID: 3323496.
20: Watts CK, Sutherland RL. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites. Mol Pharmacol. 1987 May;31(5):541-51. PubMed PMID: 3553893.
